远程治疗成功地为患有严重肥胖症的成年人提供了常规护理减肥和生活方式干预。

Remote Treatment Successfully Delivers a Usual Care Weight Loss and Lifestyle Intervention in Adults with Morbid Obesity.

作者信息

Fischer Martin, Weimann Thure, Oberänder Nadine, Schupitza Lena, Hösel Jana, Weimann Arved

机构信息

St. George Obesity Treatment Study Group, Klinikum St. Georg gGmbH, Leipzig, Germany.

Research Group Digital Health, Technische Universität Dresden, Dresden, Germany.

出版信息

Ann Nutr Metab. 2022;78(6):328-335. doi: 10.1159/000526475. Epub 2022 Aug 17.

DOI:10.1159/000526475

PMID:35977461

Abstract

INTRODUCTION

Remote delivery of behavioral and lifestyle interventions has shown a great potential for achieving weight loss comparable to in-person treatment. However, little is known about its effects on adherence and efficacy in a real-world setting. During the COVID-19 pandemic, our usual care, a 12-month treatment program for morbid obesity, had to be transitioned to remote delivery. We evaluated whether this had adverse effects on weight loss or adherence.

METHODS

We report retrospective data of 234 patients who belonged either to a cohort affected by the transition of treatment delivery (N = 117, mean age = 44.2 years; BMI = 47.7 kg/m2) or to an individually matched control group treated prior to the pandemic (N = 117, 44.4 years; 47.3 kg/m2). Weight loss, dropouts, and attendance were compared between both groups and between remote and regular treatment periods.

RESULTS

Weight loss and the number of dropouts did not differ between the two groups and between treatment periods. However, attendance at remotely offered meetings was lower in the pandemic group (72.5%) when compared to the same meetings offered face to face in the control group (81.0%, p < 0.001).

DISCUSSION/CONCLUSION: Usual care weight loss and lifestyle interventions for morbid obesity can be successfully delivered via remote treatment.

摘要

引言

行为和生活方式干预的远程交付已显示出在实现体重减轻方面具有巨大潜力，可与面对面治疗相媲美。然而，对于其在现实环境中对依从性和疗效的影响知之甚少。在新冠疫情期间，我们针对病态肥胖的常规护理，即一个为期12个月的治疗项目，不得不转变为远程交付。我们评估了这是否对体重减轻或依从性产生不利影响。

方法

我们报告了234名患者的回顾性数据，这些患者要么属于受治疗交付转变影响的队列（N = 117，平均年龄 = 44.2岁；BMI = 47.7 kg/m²），要么属于疫情大流行前接受治疗的个体匹配对照组（N = 117，44.4岁；47.3 kg/m²）。比较了两组之间以及远程治疗期和常规治疗期之间的体重减轻、退出率和出勤率。